ED Coding & Reimbursement Alert - 2004 Issue 42
Medicare Advantage: New Carotid Stent Technique Wins Coverage
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS coverage update for carotid artery stent placement performed with PTA in connection with FDA-approved devices and an FDA-required post-approval study. It is relevant to physician practices, interventional specialists, and coding or reimbursement teams tracking Medicare Advantage and CMS policy changes related to carotid artery disease treatment.
Why This Topic Matters
Coverage policy changes can affect whether a procedure is payable, how practices document cases, and how teams interpret Medicare requirements tied to FDA studies and carotid stenosis treatment. The article is useful for readers who need to understand the policy environment around this service and the types of clinical criteria CMS is discussing.
What You Will Learn
- How CMS is approaching coverage for carotid artery stent placement with PTA
- The role of FDA-approved devices and post-approval studies in the policy discussion
- The general clinical context for carotid artery disease treatment and Medicare coverage
- The broad patient characteristics CMS associates with this coverage decision
Who Should Read This
- Physician practices
- Interventional cardiology teams
- Vascular surgery teams
- Medical coders
- Reimbursement specialists
- Compliance staff
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com